News

HIMSS battle plan (Morning Read)

Among today’s current medical news: HIMSS advice, new firepower to defend healthcare reform, Eli Lilly’s new R & D incentives, major rehab center M&A and preterm birth prevention drug wins FDA approval.

Current medical news and unique business news for anyone who cares about the healthcare industry.

HIMSS battle plan. Healthcare’s nerd alert – HIMSS – is in two weeks. Roughly 30,000 of Health IT”s key players will come together for a sneak peek at what’s coming next in the field. Chilmark Research provides a list of ways to prepare for the conference and some practical tips (hint: keep your meetings short).

Lilly bonuses now tied to pipeline. Progress of product pipeline — including FDA approvals and Phase III trials — will now be factored into Eli Lilly’s employee bonuses. “By realigning payouts, Lilly hopes to empower employees, since drugmakers are experiencing enormous upheaval at varying times due to differing dates for patent expirations on best-selling meds,” writes Pharmalot. “Given recent developments, though, Lilly employees may wonder about the likelihood of receiving extra cash.

Obamacare’s heavy hitters. Groups including Families USA, Health Care for America Now and the Center for American Progress are gathering top strategists for a new initiative to battle GOP efforts against healthcare reform legislation.

Rehab center giant. Kindred Healthcare has acquired RehabCare Group for $877 million, making it the biggest largest U.S. operator of health-rehabilitation centers.

FDA approves 17-HP. The pre-term birth drug could prevent about 10,000 premature births annually.

Dealflow and more. Cancer drug developer EpiCept is raising $7.1 million; urology device maker NeoTract raised $25.9 million; Pfizer acquired dietary supplements company Ferrosan.

Topics